MGS and KraussMaffei: Scaling medical production worldwide

High-volume medical projects for global healthcare markets demand speed, repeatability and absolute confidence in every part produced. MGS, headquartered in Germantown, Wisconsin (USA), provides the full value chain – from the first drawing to the packaged component – leveraging the injection molding machinery expertise of KraussMaffei. Rapid growth dynamics often emerge when multiple all-electric PX injection molding machines are required simultaneously.

CDMO – Contract Development and Manufacturing Organization – defines MGS value proposition. From development through delivery of finished products, every project must run flawlessly – because in pharma, diagnostics and medtech, it ultimately comes down to patient health. Dirk Paulmann, Vice President of Global Marketing of MGS, puts it this way: “We’re in the Champions League when it comes to volume, precision, and quality. To achieve this, we need the right partners.”

A global service network that builds confidence

To meet these high standards, MGS has counted on KraussMaffei machines for many years. A cornerstone is the all-electric PX with LRX linear robots in its medical configuration – featuring, among other options, automatic centralized lubrication in a closed circuit. The platform is ideally suited for ISO Class 8 cleanroom manufacturing, which MGS operates with approximately 1,500 employees across sites in the United States, Costa Rica, Mexico, Ireland, Sweden, Germany, Belgium, Denmark, and Slovakia. Through its international service network, KraussMaffei offers customers like MGS the assurance that a competent contact person is always quickly available on-site for maintenance or to solve problems.

Pic.All-electric PX injection molding machines from KraussMaffei equipped with LRX linear robots in production at MGS in Richfield. (Foto: MGS)

Consistency across every cavity matters

Many MGS programs run multi-cavity molds at demanding cycle times, making repeatability across every cavity essential. Since MGS projects typically involve multi-cavity molds running at fast cycle times, process repeatability across all cavities is critical. For low part weights, such as those of laboratory materials, not only is precise hot runner technology required, but also machines that guarantee a completely constant shot weight. KraussMaffei’s APCplus function offers the ideal digital solution for this. It optimally adjusts the switching point and holding pressure from shot to shot to match the respective melt viscosity.

Keeping up with rapid growth

KraussMaffei is also valued for its ability to help MGS ramp advanced production quickly when medtech programs launch successfully. The team led by Thomas Hörl, Key Account Manager Medical at KraussMaffei in Parsdorf, has supported orders for multiple machines at once – delivering and commissioning them on tight timelines. For Dirk Paulmann, that responsiveness is critical: “We need partners who can keep pace with our customers’ growth rates. KraussMaffei has proven several times that it is equal to this major challenge.”

Future growth driver: A.i.r. Platform™

One innovation poised to drive further growth is the proprietary A.i.r. Platform™ (Auto-injector reimagined). Built around a fully certified internal mechanism, the platform gives MGS customers access to a proven, ready-to-use system – while allowing the external design and user interface to be customized to brand, therapy and patient needs. The result is shorter development timelines, lower technical risk, and a more efficient path through regulatory requirements toward market launch.

To support the increasing demand for this product, MGS needs a long-standing partner like KraussMaffei which Dirk Paulmann particularly values for “the high level of attention and support we receive.”, that provides a strong foundation for the future partnership.